Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
-
* Corresponding author: Jaro Wex jaro.wex@pharmarchitecture.com
- Equal contributors
BMC Pregnancy and Childbirth 2009, 9:23 doi:10.1186/1471-2393-9-23
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 31 Oct 2008 | |
| Reviewer's Report | Vicki Flenady | 04 Jan 2009 | |
| Reviewer's Report | Hanns Helmer | 09 Feb 2009 | |
| Reviewer's Report | Girdhar Agarwal | 20 Feb 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 13 Mar 2009 |
| Reviewer's Report | Martin Duerden | 01 Jun 2009 | |
| Editorial acceptance | 01 Jun 2009 | ||
| Published | 19 Jun 2009 |